Cart  |  Log In


Antibody Assistant

Anti-ACTIVE® JNK pAb

Anti-ACTIVE® JNK pAb, Rabbit (Cat.# V7931) is an affinity-purified polyclonal antibody that recognizes the dually phosphorylated, active form of JNK (c-Jun N-terminal protein kinase), also known as SAPK (Stress-Activated Protein Kinase). Anti-ACTIVE® JNK pAb is raised against a dually phosphorylated peptide sequence representing the catalytic core of the active JNK enzyme. The phosphorylated amino acid residues correspond to Thr 183 and Tyr 185 of the JNK2 enzyme.

  • Specificity: Preferentially detects the dually phosphorylated, active form of the stress-activated protein kinase (SAPK), also known as c-Jun N-terminal kinase, JNK.
  • Immunogen: Dually phosphorylated Thr/Pro/Tyr region (pTPpY) derived from the catalytic core of the active form of JNK kinase, corresponding to Thr183 and Tyr185 of the mammalian JNK2 enzyme.
  • Antibody Form: Affinity purified Rabbit IgG; supplied in 10mM sodium phosphate, 20mM NaCl (pH 7.4).
  • Value: Anti-ACTIVE® JNK pAb is available in two convenient sizes. Cat.# V7931 will generate up to 200ml of blotting solution, sufficient for 20 Western blots of 10ml each. The larger size, Cat.# V7932 will generate up to 600ml of blotting solution, sufficient for 60 Western blots of 10ml each.

Promega Product Information Sheet (.pdf, 37kb):


Western Blotting

Protocol:

  • Technical Bulletin #TB262: Anti-ACTIVE® MAPK, p38 and JNK Polyclonal Antibodies and Anti-ACTIVE® Qualified Secondary Antibody Conjugates–Contains Promega's optimized protocol for Western analysis of extracts and has different optimized protocols for PVDF membranes or nitrocellulose membranes.

Technical Literature:

  • Jarvis, B.W. and O'Brien, M. (1999) PC12 Extracts for use with new Anti-pT183 MAPK and Anti-ACTIVE® Antibodies. Promega Notes 72, 10–12.—Western blots of new Sorbitol-treated and untreated PC12 Cell Extracts (Cat.# V8100).
  • Using Anti-ACTIVE® MAPK, p38 and JNK pAbs for Western blotting. Neural Notes 18, 12–13.

Citations for Western Blot Analysis


Immunocytochemistry

Protocol:

  • Technical Bulletin #TB262:Anti-ACTIVE® MAPK, p38 and JNK Polyclonal Antibodies and Anti-ACTIVE® Qualified Secondary Antibody Conjugates.–Contains Promega's optimized protocol for immunocytochemical analysis of JNK in PC12 cells treated with Sorbitol.

Technical Literature:

  • Immunostaining with the new Anti-ACTIVE® p38 Antibody. Neural Notes 17, 2–4.–ICC of Sorbitol-treated PC12 cells.
  • Imaging with Promega Reagents No. 9. Neural Notes 17, 10 (.pdf, 303kb).—Tau-1 staining patterns are altered in apoptotic cells (PC12) possessing active JNK in the nucleus.–Referenced to Davis, P.K. and Johnson, G.V.W.(1999) J. Biol. Chem.
    274, 35686–92.

Citations for Immunocytochemistry


Immunohistochemistry

Technical Literature:

Hoffman, R., O'Brien, M. and Jarvis, B.W. (2001) Immunohistochemical staining using Promega Anti-ACTIVE® and Apoptosis Antibodies. Cell Notes 1, 4–7.—IHC of rat brain hippocampus with the Anti-ACTIVE® JNK pAb and Anti-ACTIVE® p38 pAb. Full protocols are provided.

Citations for Immunohistochemistry


Cross-Reactivity Citations

For information regarding species cross-reactivity, please select one of the following species for a list of citations: